Cargando…
The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012
INTRODUCTION: The English Department of Health introduced universal MRSA screening of admissions to English hospitals in 2010. It commissioned a national audit to review implementation, impact on patient management, admission prevalence and extra yield of MRSA identified compared to “high-risk” spec...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772122/ https://www.ncbi.nlm.nih.gov/pubmed/24069282 http://dx.doi.org/10.1371/journal.pone.0074219 |
_version_ | 1782284289140850688 |
---|---|
author | Fuller, Christopher Robotham, Julie Savage, Joanne Hopkins, Susan Deeny, Sarah R. Stone, Sheldon Cookson, Barry |
author_facet | Fuller, Christopher Robotham, Julie Savage, Joanne Hopkins, Susan Deeny, Sarah R. Stone, Sheldon Cookson, Barry |
author_sort | Fuller, Christopher |
collection | PubMed |
description | INTRODUCTION: The English Department of Health introduced universal MRSA screening of admissions to English hospitals in 2010. It commissioned a national audit to review implementation, impact on patient management, admission prevalence and extra yield of MRSA identified compared to “high-risk” specialty or “checklist-activated” screening (CLAS) of patients with MRSA risk factors. METHODS: National audit May 2011. Questionnaires to infection control teams in all English NHS acute trusts, requesting number patients admitted and screened, new or previously known MRSA; MRSA point prevalence; screening and isolation policies; individual risk factors and patient management for all new MRSA patients and random sample of negatives. RESULTS: 144/167 (86.2%) trusts responded. Individual patient data for 760 new MRSA patients and 951 negatives. 61% of emergency admissions (median 67.3%), 81% (median 59.4%) electives and 47% (median 41.4%) day-cases were screened. MRSA admission prevalence: 1% (median 0.9%) emergencies, 0.6% (median 0.4%) electives, 0.4% (median 0%) day-cases. Approximately 50% all MRSA identified was new. Inpatient MRSA point prevalence: 3.3% (median 2.9%). 104 (77%) trusts pre-emptively isolated patients with previous MRSA, 63 (35%) pre-emptively isolated admissions to “high-risk” specialties; 7 (5%) used PCR routinely. Mean time to MRSA positive result: 2.87 days (±1.33); 37% (219/596) newly identified MRSA patients discharged before result available; 55% remainder (205/376) isolated post-result. In an average trust, CLAS would reduce screening by 50%, identifying 81% of all MRSA. “High risk” specialty screening would reduce screening by 89%, identifying 9% of MRSA. CONCLUSIONS: Implementation of universal screening was poor. Admission prevalence (new cases) was low. CLAS reduced screening effort for minor decreases in identification, but implementation may prove difficult. Cost effectiveness of this and other policies, awaits evaluation by transmission dynamic economic modelling, using data from this audit. Until then trusts should seek to improve implementation of current policy and use of isolation facilities. |
format | Online Article Text |
id | pubmed-3772122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37721222013-09-25 The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012 Fuller, Christopher Robotham, Julie Savage, Joanne Hopkins, Susan Deeny, Sarah R. Stone, Sheldon Cookson, Barry PLoS One Research Article INTRODUCTION: The English Department of Health introduced universal MRSA screening of admissions to English hospitals in 2010. It commissioned a national audit to review implementation, impact on patient management, admission prevalence and extra yield of MRSA identified compared to “high-risk” specialty or “checklist-activated” screening (CLAS) of patients with MRSA risk factors. METHODS: National audit May 2011. Questionnaires to infection control teams in all English NHS acute trusts, requesting number patients admitted and screened, new or previously known MRSA; MRSA point prevalence; screening and isolation policies; individual risk factors and patient management for all new MRSA patients and random sample of negatives. RESULTS: 144/167 (86.2%) trusts responded. Individual patient data for 760 new MRSA patients and 951 negatives. 61% of emergency admissions (median 67.3%), 81% (median 59.4%) electives and 47% (median 41.4%) day-cases were screened. MRSA admission prevalence: 1% (median 0.9%) emergencies, 0.6% (median 0.4%) electives, 0.4% (median 0%) day-cases. Approximately 50% all MRSA identified was new. Inpatient MRSA point prevalence: 3.3% (median 2.9%). 104 (77%) trusts pre-emptively isolated patients with previous MRSA, 63 (35%) pre-emptively isolated admissions to “high-risk” specialties; 7 (5%) used PCR routinely. Mean time to MRSA positive result: 2.87 days (±1.33); 37% (219/596) newly identified MRSA patients discharged before result available; 55% remainder (205/376) isolated post-result. In an average trust, CLAS would reduce screening by 50%, identifying 81% of all MRSA. “High risk” specialty screening would reduce screening by 89%, identifying 9% of MRSA. CONCLUSIONS: Implementation of universal screening was poor. Admission prevalence (new cases) was low. CLAS reduced screening effort for minor decreases in identification, but implementation may prove difficult. Cost effectiveness of this and other policies, awaits evaluation by transmission dynamic economic modelling, using data from this audit. Until then trusts should seek to improve implementation of current policy and use of isolation facilities. Public Library of Science 2013-09-12 /pmc/articles/PMC3772122/ /pubmed/24069282 http://dx.doi.org/10.1371/journal.pone.0074219 Text en © 2013 Fuller et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Fuller, Christopher Robotham, Julie Savage, Joanne Hopkins, Susan Deeny, Sarah R. Stone, Sheldon Cookson, Barry The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012 |
title | The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012 |
title_full | The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012 |
title_fullStr | The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012 |
title_full_unstemmed | The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012 |
title_short | The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012 |
title_sort | national one week prevalence audit of universal meticillin-resistant staphylococcus aureus (mrsa) admission screening 2012 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772122/ https://www.ncbi.nlm.nih.gov/pubmed/24069282 http://dx.doi.org/10.1371/journal.pone.0074219 |
work_keys_str_mv | AT fullerchristopher thenationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT robothamjulie thenationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT savagejoanne thenationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT hopkinssusan thenationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT deenysarahr thenationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT stonesheldon thenationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT cooksonbarry thenationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT fullerchristopher nationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT robothamjulie nationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT savagejoanne nationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT hopkinssusan nationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT deenysarahr nationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT stonesheldon nationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 AT cooksonbarry nationaloneweekprevalenceauditofuniversalmeticillinresistantstaphylococcusaureusmrsaadmissionscreening2012 |